Home ETF List About

Portfolio Holdings Detail for ISIN IE00BKBF6H24
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / FundiShares Core MSCI World UCITS ETF
IssuerBlackrock
ETF TickerIWLE(EUR) F
ETF TickerIWLE.DE(EUR) CXE

Holdings detail for NTRA

Stock NameNatera Inc
TickerNTRA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6323071042

Show aggregate NTRA holdings

News associated with NTRA

Financial Contrast: Natera (NASDAQ:NTRA) & Oncology Institute (NASDAQ:TOI)
Natera (NASDAQ:NTRA – Get Free Report) and Oncology Institute (NASDAQ:TOI – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Institutional and Insider Ownership 99.9% of Natera shares are […] - 2025-09-17 03:14:43
Natera (NASDAQ:NTRA) Stock Acquired Rep. Josh Gottheimer
Representative Josh Gottheimer (D-New Jersey) recently bought shares of Natera, Inc. (NASDAQ:NTRA). In a filing disclosed on September 05th, the Representative disclosed that they had bought between $1,001 and $15,000 in Natera stock on August 22nd. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account. Representative Josh Gottheimer also […] - 2025-09-09 03:10:46
Natera, Inc. (NASDAQ:NTRA) Receives $194.00 Average Price Target from Brokerages
Natera, Inc. (NASDAQ:NTRA – Get Free Report) has earned a consensus rating of “Buy” from the eighteen ratings firms that are covering the firm, Marketbeat Ratings reports. Seventeen research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target […] - 2025-09-08 03:08:53
Rowan Chapman Sells 2,750 Shares of Natera (NASDAQ:NTRA) Stock
Natera, Inc. (NASDAQ:NTRA – Get Free Report) Director Rowan Chapman sold 2,750 shares of the firm’s stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $166.99, for a total value of $459,222.50. Following the completion of the sale, the director directly owned 6,015 shares in […] - 2025-09-04 05:23:03
Financial Survey: Natera (NASDAQ:NTRA) vs. Solventum (NYSE:SOLV)
Natera (NASDAQ:NTRA – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Analyst Recommendations This is a summary of current ratings […] - 2025-08-15 05:40:53
Natera, Inc. (NASDAQ:NTRA) Receives $192.53 Consensus Target Price from Analysts
Natera, Inc. (NASDAQ:NTRA – Get Free Report) has earned an average recommendation of “Buy” from the seventeen ratings firms that are covering the company, MarketBeat reports. Sixteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts […] - 2025-08-14 03:07:06
Deutsche Bank AG Purchases 160,243 Shares of Natera, Inc. (NASDAQ:NTRA)
Deutsche Bank AG raised its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 185.8% in the first quarter, HoldingsChannel reports. The firm owned 246,482 shares of the medical research company’s stock after acquiring an additional 160,243 shares during the period. Deutsche Bank AG’s holdings in Natera were worth $34,855,000 as of its […] - 2025-08-13 05:24:57
Charles Schwab Investment Management Inc. Raises Holdings in Natera, Inc. (NASDAQ:NTRA)
Charles Schwab Investment Management Inc. boosted its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 4.4% in the 1st quarter, HoldingsChannel reports. The fund owned 905,676 shares of the medical research company’s stock after buying an additional 38,180 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Natera were worth […] - 2025-08-12 05:23:02
NTRA Makes Bullish Cross Above Critical Moving Average
In trading on Friday, shares of Natera Inc (Symbol: NTRA) crossed above their 200 day moving average of $154.62, changing hands as high as $165.09 per share. Natera Inc shares are currently trading up about 11.7% on the day. The chart below shows the one year performance of NT - 2025-08-08 12:49:35
Harbour Investments Inc. Has $139,000 Stock Position in Natera, Inc. (NASDAQ:NTRA)
Harbour Investments Inc. raised its holdings in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 57.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 983 shares of the medical research company’s stock after buying an additional 359 shares […] - 2025-08-08 05:26:55
Natera, Inc. (NASDAQ:NTRA) Shares Purchased by HighPoint Advisor Group LLC
HighPoint Advisor Group LLC lifted its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 30.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,986 shares of the medical research company’s stock after purchasing an additional 468 shares during […] - 2025-07-24 08:19:53
Solomon Moshkevich Sells 1,649 Shares of Natera, Inc. (NASDAQ:NTRA) Stock
Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider Solomon Moshkevich sold 1,649 shares of the stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $156.85, for a total transaction of $258,645.65. Following the completion of the sale, the insider owned 128,556 shares of the company’s stock, valued […] - 2025-07-24 06:20:52
Notable Two Hundred Day Moving Average Cross - NTRA
In trading on Tuesday, shares of Natera Inc (Symbol: NTRA) crossed below their 200 day moving average of $153.49, changing hands as low as $152.02 per share. Natera Inc shares are currently trading off about 3.6% on the day. The chart below shows the one year performance of NT - 2025-07-15 12:33:44
Cerity Partners LLC Has $12.11 Million Stock Position in Natera, Inc. (NASDAQ:NTRA)
Cerity Partners LLC raised its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 7.3% in the first quarter, HoldingsChannel.com reports. The firm owned 85,645 shares of the medical research company’s stock after purchasing an additional 5,863 shares during the quarter. Cerity Partners LLC’s holdings in Natera were worth $12,111,000 at the end […] - 2025-07-15 07:46:49
Oppenheimer Asset Management Inc. Trims Holdings in Natera, Inc. (NASDAQ:NTRA)
Oppenheimer Asset Management Inc. decreased its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 12.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 17,744 shares of the medical research company’s stock after selling 2,515 shares during the period. […] - 2025-06-27 05:38:46
Analysts Anticipate 10% Upside For TGRT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-26 12:59:13
ORG Partners LLC Purchases Shares of 233 Natera, Inc. (NASDAQ:NTRA)
ORG Partners LLC bought a new position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) during the first quarter, HoldingsChannel.com reports. The firm bought 233 shares of the medical research company’s stock, valued at approximately $32,000. A number of other institutional investors and hedge funds have also recently made changes to their positions in […] - 2025-06-23 05:08:59
Exchange Traded Concepts LLC Buys 871 Shares of Natera, Inc. (NASDAQ:NTRA)
Exchange Traded Concepts LLC increased its holdings in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 15.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,458 shares of the medical research company’s stock after buying an additional 871 shares during […] - 2025-06-20 05:49:06
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Fifth Third Bancorp
Fifth Third Bancorp cut its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 81.1% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,064 shares of the medical research company’s stock after selling 4,565 shares during the period. Fifth Third Bancorp’s holdings […] - 2025-06-20 04:46:49
XBI, EXAS, NBIX, NTRA: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $443.9 million dollar outflow -- that's a 8.8% decrease week over week - 2025-06-17 11:54:37
Wedmont Private Capital Buys Shares of 1,506 Natera, Inc. (NASDAQ:NTRA)
Wedmont Private Capital purchased a new position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,506 shares of the medical research company’s stock, valued at approximately $223,000. A number of other institutional investors have also […] - 2025-06-12 05:35:00
GAMMA Investing LLC Increases Stock Holdings in Natera, Inc. (NASDAQ:NTRA)
GAMMA Investing LLC boosted its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 18,607.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 119,916 shares of the medical research company’s stock after purchasing an additional 119,275 shares during the quarter. […] - 2025-06-06 05:48:57
Mackenzie Financial Corp Purchases 1,092 Shares of Natera, Inc. (NASDAQ:NTRA)
Mackenzie Financial Corp lifted its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 33.9% during the fourth quarter, HoldingsChannel reports. The firm owned 4,317 shares of the medical research company’s stock after buying an additional 1,092 shares during the quarter. Mackenzie Financial Corp’s holdings in Natera were worth $683,000 at the end […] - 2025-06-02 05:53:03
Notable ETF Outflow Detected - XBI, EXAS, NBIX, NTRA
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $257.5 million dollar outflow -- that's a 5.2% decrease week over week - 2025-05-30 14:40:38
Peek Under The Hood: ILCG Has 14% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 10:36:15
Quantinno Capital Management LP Takes $373,000 Position in Natera, Inc. (NASDAQ:NTRA)
Quantinno Capital Management LP bought a new position in Natera, Inc. (NASDAQ:NTRA – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 2,356 shares of the medical research company’s stock, valued at approximately $373,000. Other institutional investors also recently bought and sold shares of the company. […] - 2025-05-26 04:57:03
SPDR S&P Biotech ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $140.8 million dollar outflow -- that's a 2.8% decrease week over week - 2025-05-22 11:55:21
Lazard Asset Management LLC Buys 551 Shares of Natera, Inc. (NASDAQ:NTRA)
Lazard Asset Management LLC raised its stake in Natera, Inc. (NASDAQ:NTRA – Free Report) by 22.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,052 shares of the medical research company’s stock after acquiring an additional 551 shares during the period. Lazard Asset […] - 2025-05-22 05:48:58
Focus Partners Wealth Purchases 1,442 Shares of Natera, Inc. (NASDAQ:NTRA)
Focus Partners Wealth raised its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 35.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,519 shares of the medical research company’s stock after purchasing an additional 1,442 shares during the period. […] - 2025-05-19 05:20:56
Cetera Investment Advisers Cuts Stake in Natera, Inc. (NASDAQ:NTRA)
Cetera Investment Advisers reduced its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 8.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 13,145 shares of the medical research company’s stock after selling 1,176 shares during the period. Cetera Investment Advisers’ holdings in Natera were worth […] - 2025-05-19 04:38:49

iShares Core MSCI World UCITS ETF NTRA holdings

DateNumber of NTRA Shares HeldBase Market Value of NTRA SharesLocal Market Value of NTRA SharesChange in NTRA Shares HeldChange in NTRA Base ValueCurrent Price per NTRA Share HeldPrevious Price per NTRA Share Held
2025-11-12 (Wednesday)193,263USD 40,488,599USD 40,488,599
2025-11-11 (Tuesday)193,263USD 39,951,327NTRA holding increased by 17393USD 39,951,3270USD 17,393 USD 206.72 USD 206.63
2025-11-10 (Monday)193,263NTRA holding increased by 112USD 39,933,934NTRA holding increased by 1386789USD 39,933,934112USD 1,386,789 USD 206.63 USD 199.57
2025-11-07 (Friday)193,151NTRA holding increased by 189USD 38,547,145NTRA holding increased by 248047USD 38,547,145189USD 248,047 USD 199.57 USD 198.48
2025-11-06 (Thursday)192,962USD 38,299,098NTRA holding decreased by -277865USD 38,299,0980USD -277,865 USD 198.48 USD 199.92
2025-11-05 (Wednesday)192,962NTRA holding increased by 135USD 38,576,963NTRA holding increased by 696099USD 38,576,963135USD 696,099 USD 199.92 USD 196.45
2025-11-04 (Tuesday)192,827NTRA holding increased by 840USD 37,880,864NTRA holding decreased by -176719USD 37,880,864840USD -176,719 USD 196.45 USD 198.23
2025-11-03 (Monday)191,987NTRA holding increased by 588USD 38,057,583NTRA holding decreased by -17420USD 38,057,583588USD -17,420 USD 198.23 USD 198.93
2025-10-31 (Friday)191,399NTRA holding increased by 336USD 38,075,003NTRA holding increased by 1157810USD 38,075,003336USD 1,157,810 USD 198.93 USD 193.22
2025-10-30 (Thursday)191,063NTRA holding increased by 84USD 36,917,193NTRA holding increased by 94532USD 36,917,19384USD 94,532 USD 193.22 USD 192.81
2025-10-29 (Wednesday)190,979NTRA holding increased by 252USD 36,822,661NTRA holding increased by 666544USD 36,822,661252USD 666,544 USD 192.81 USD 189.57
2025-10-28 (Tuesday)190,727USD 36,156,117NTRA holding decreased by -505427USD 36,156,1170USD -505,427 USD 189.57 USD 192.22
2025-10-27 (Monday)190,727USD 36,661,544NTRA holding decreased by -55311USD 36,661,5440USD -55,311 USD 192.22 USD 192.51
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NTRA by Blackrock for IE00BKBF6H24

Show aggregate share trades of NTRA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY112210.900199.730 200.847USD 22,495 159.90
2025-11-07BUY189 199.570* 159.59
2025-11-05BUY135201.940193.290 194.155USD 26,211 158.96
2025-11-04BUY840203.225195.621 196.382USD 164,961 158.66
2025-11-03BUY588200.760194.070 194.739USD 114,507 158.35
2025-10-31BUY336199.210192.290 192.982USD 64,842 158.02
2025-10-30BUY84198.560190.560 191.360USD 16,074 157.73
2025-10-29BUY252192.810195.120 194.889USD 49,112 157.44
2025-10-24BUY308192.510198.990 198.342USD 61,089 156.57
2025-10-20BUY196188.600196.630 195.827USD 38,382 155.41
2025-10-17BUY252181.690182.420 182.347USD 45,951 155.18
2025-10-03BUY196167.350167.910 167.854USD 32,899 154.17
2025-10-01BUY196161.610163.400 163.221USD 31,991 154.04
2025-09-26SELL-1,232162.970164.694 164.522USD -202,691 153.80 Loss of -13,211 on sale
2025-09-18BUY224179.860180.600 180.526USD 40,438 153.33
2025-08-06BUY392138.130140.740 140.479USD 55,068 153.16
2025-08-05BUY588140.120141.450 141.317USD 83,094 153.30
2025-08-04BUY464136.570137.080 137.029USD 63,581 153.48
2025-08-01BUY112134.580136.280 136.110USD 15,244 153.69
2025-07-16BUY112148.400151.087 150.818USD 16,892 153.86
2025-07-14BUY196158.180161.420 161.096USD 31,575 153.86
2025-07-11BUY112160.430163.395 163.099USD 18,267 153.78
2025-07-09BUY168161.750164.630 164.342USD 27,609 153.57
2025-07-08BUY84158.480160.330 160.145USD 13,452 153.52
2025-07-07BUY224158.690161.435 161.160USD 36,100 153.45
2025-07-02BUY486161.570163.230 163.064USD 79,249 153.14
2025-06-30BUY675168.940170.145 170.025USD 114,767 152.94
2025-06-18BUY189170.980172.730 172.555USD 32,613 151.62
2025-06-04BUY540167.220169.430 169.209USD 91,373 149.62
2025-06-03BUY81160.150162.420 162.193USD 13,138 149.45
2025-05-16BUY112152.590153.400 153.319USD 17,172 148.04
2025-05-09BUY135151.950166.000 164.595USD 22,220 147.77
2025-05-06BUY162155.500158.446 158.151USD 25,621 146.98
2025-04-30BUY112150.930152.520 152.361USD 17,064 146.26
2025-04-25BUY270153.790155.500 155.329USD 41,939 145.65
2025-04-24BUY216154.480154.560 154.552USD 33,383 145.40
2025-04-23BUY108148.560153.490 152.997USD 16,524 145.31
2025-04-17BUY168148.080150.090 149.889USD 25,181 145.25
2025-04-16BUY224150.170152.000 151.817USD 34,007 145.09
2025-04-15BUY476151.740152.660 152.568USD 72,622 144.86
2025-04-14BUY196148.450152.500 152.095USD 29,811 144.73
2025-04-11BUY476148.040148.980 148.886USD 70,870 144.61
2025-04-10BUY112143.280147.240 146.844USD 16,447 144.66
2025-04-09BUY703151.970153.000 152.897USD 107,487 144.37
2025-04-08SELL-46132.230144.750 143.498USD -6,601 144.87 Profit of 63 on sale
2025-04-07SELL-140138.260141.400 141.086USD -19,752 145.16 Profit of 571 on sale
2025-04-04BUY168133.870136.395 136.143USD 22,872 145.68
2025-03-31BUY756141.410142.920 142.769USD 107,933 146.29
2025-03-27BUY162148.300152.750 152.305USD 24,673 146.31
2025-03-26BUY540149.840154.700 154.214USD 83,276 146.09
2025-03-24BUY135153.830154.990 154.874USD 20,908 144.94
2025-03-19BUY243150.870153.590 153.318USD 37,256 143.40
2025-03-17BUY459149.250151.830 151.572USD 69,572 142.44
2025-03-11BUY324140.020142.180 141.964USD 45,996 141.33
2025-03-07BUY81140.660143.410 143.135USD 11,594 144.46
2025-03-05BUY324147.920148.280 148.244USD 48,031 142.73
2025-03-04BUY216142.350145.330 145.032USD 31,327 143.11
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NTRA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19126,2600232,63154.3%
2025-09-18144,24118274,55952.5%
2025-09-17102,8110191,09653.8%
2025-09-16163,3050322,09250.7%
2025-09-15156,6200366,93342.7%
2025-09-12158,712429293,33454.1%
2025-09-11158,8820296,49253.6%
2025-09-10196,055571488,41140.1%
2025-09-09295,3272,214529,76655.7%
2025-09-08127,8734,558341,37237.5%
2025-09-05139,247557240,08058.0%
2025-09-04114,9270340,92033.7%
2025-09-03132,14715431,80330.6%
2025-09-02128,238100366,75435.0%
2025-08-29153,2401285,28853.7%
2025-08-28174,2574,763367,92247.4%
2025-08-27145,7628294,09749.6%
2025-08-26208,7912,816345,67960.4%
2025-08-25266,388906451,97358.9%
2025-08-22175,2122,003308,50356.8%
2025-08-21170,741495291,58758.6%
2025-08-20203,3530572,80035.5%
2025-08-19170,7540361,90647.2%
2025-08-18256,114548697,79336.7%
2025-08-15279,8541,024482,55058.0%
2025-08-14118,4052,294220,43653.7%
2025-08-13163,1600412,23339.6%
2025-08-12407,38557745,52354.6%
2025-08-11345,127750727,13847.5%
2025-08-08698,2702,9291,441,31448.4%
2025-08-07859,77511,530,36456.2%
2025-08-06413,2250891,10046.4%
2025-08-05455,46779913,55949.9%
2025-08-04266,22059690,58438.5%
2025-08-01231,876153545,80642.5%
2025-07-31287,33241581,20149.4%
2025-07-30295,217111461,18364.0%
2025-07-29302,452295553,32954.7%
2025-07-28502,479154,335728,11569.0%
2025-07-25377,677280580,86665.0%
2025-07-24400,5231,264696,54857.5%
2025-07-23337,2771,015949,56135.5%
2025-07-22259,235270490,00552.9%
2025-07-21380,2442,771604,16362.9%
2025-07-18220,88811,544543,87340.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.